Wayne Batchelor

2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

Nonrandomized Comparison of Coronary Artery Bypass Surgery and Percutaneous Coronary Intervention for the Treatment of Unprotected Left Main Coronary Artery Disease in Octogenarians

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials

Tirofiban for the treatment of ischaemic stroke

Evaluation of aspirin metabolites as inhibitors of hypoxia-inducible factor hydroxylases

A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease

Physical and mechanical properties of PLA, and their functions in widespread applications — A comprehensive review

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

Calcium's Role in Mechanotransduction during Muscle Development

Circulating Endothelial Progenitor Cells and Cardiovascular Outcomes

Heart failure and the aging population: an increasing burden in the 21st century?

ACCF/AHA New Insights Into the Methodology of Performance Measurement

Bivalirudin during Primary PCI in Acute Myocardial Infarction

Waiting times, revascularization modality, and outcomes after acute myocardial infarction at hospitals with and without on-site revascularization facilities in Canada

Association of door-to-balloon time and mortality in patients admitted to hospital with ST elevation myocardial infarction: national cohort study

Mechanotransduction and extracellular matrix homeostasis

A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease

Comparison of radial versus femoral approach for percutaneous coronary interventions in octogenarians

Percutaneous Intervention Versus Coronary Bypass Surgery for Patients Older Than 70 Years of Age With High-Risk Unstable Angina

Comparison of transradial and transfemoral approaches for coronary angiography and angioplasty in octogenarians (the OCTOPLUS study)

Diagnosis, management, and treatment of hepatitis C: An update # † ‡

Trends in the Prevalence and Outcomes of Radial and Femoral Approaches to Percutaneous Coronary Intervention

Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial

Sex and gender: modifiers of health, disease, and medicine

Platelet Activation and Atherothrombosis

Herbal Hepatotoxicity

Clopidogrel Use and Long-term Clinical Outcomes After Drug-Eluting Stent Implantation

Vascular Adaptation and Mechanical Homeostasis at Tissue, Cellular, and Sub-cellular Levels

Cancer as an overhealing wound: an old hypothesis revisited

Comparison of coronary revascularization procedures in octogenarians: a systematic review and meta-analysis

Antithrombotic Therapy for Non–ST-Segment Elevation Acute Coronary Syndromes

Prevention of Venous Thromboembolism

Treatment of Hypertension in Patients 80 Years of Age or Older

The additive value of tirofiban administered with the high-dose bolus in the prevention of ischemic complications during high-risk coronary angioplasty

Home-based exercise improves functional performance and quality of life in women with diastolic heart failure

The Transradial Approach to Percutaneous Coronary Intervention

The use of radiographic contrast media during PCI: A focused review

Major noncardiac surgery following coronary stenting: When is it safe to operate?

Tirofiban as adjunctive therapy for acute coronary syndromes and percutaneous coronary intervention: a meta-analysis of randomized trials

Prevention of Venous Thromboembolism

The role of inflammation in vascular injury and repair

Variability in Extent of Platelet Function Inhibition After Administration of Optimal Dose of Glycoprotein IIb/IIIa Receptor Blockers in Patients Undergoing a High-Risk Percutaneous Coronary Intervention

Impact of bivalirudin on in‐hospital bleeding and six‐month outcomes in octogenarians undergoing percutaneous coronary intervention

Human tissue-engineered blood vessels for adult arterial revascularization

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin

Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions

Antithrombotic Therapy During Percutaneous Coronary Intervention

Asymmetric Multicomponent Reactions (AMCRs): The New Frontier

Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation

Complete Inhibition of Intimal Hyperplasia by Perivascular Delivery of Paclitaxel in Balloon-injured Rat Carotid Arteries

Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association

Procedural and long-term outcome of primary percutaneous coronary intervention in octogenarians

Hemorrhagic Complications of Anticoagulant Treatment

Functional overlap between two classes of matrix-degrading proteases in wound healing

Platelet-Active Drugs

Coronary Stents

Platelet-Active Drugs: The Relationships Among Dose, Effectiveness, and Side Effects

Reperfusion therapy in elderly patients with acute myocardial infarction

Iron-Catalyzed Reactions in Organic Synthesis

Standardized Bleeding Definitions for Cardiovascular Clinical Trials

Guidelines for the Early Management of Patients With Acute Ischemic Stroke

Regulation of Tenascin-C, a Vascular Smooth Muscle Cell Survival Factor that Interacts with the αvβ3 Integrin to Promote Epidermal Growth Factor Receptor Phosphorylation and Growth

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Quantity and Quality of Exercise for Developing and Maintaining Cardiorespiratory, Musculoskeletal, and Neuromotor Fitness in Apparently Healthy Adults

Prevalence, Predictors, and Outcomes of Premature Discontinuation of Thienopyridine Therapy After Drug-Eluting Stent Placement

ACC/AHA guidelines for coronary angiography11“ACC/AHA Guidelines for Coronary Angiography” was approved by the American College of Cardiology Board of Trustees in October 1998 and by the American Heart Association Science Advisory and Coordinating Committee in December 1998.22When citing this document, the American College of Cardiology and the American Heart Association request that the following format be used: Scanlon PJ, Faxon DP, Audet AM, Carabello B, Dehmer GJ, Eagle KA, Legako RD, Leon DF, Murray JA, Nissen SD, Pepine CJ, Watson RM. ACC/AHA guidelines for coronary angiography: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography). J Am Coll Cardiol1999;33:1756–82433This document is available on the websites of the ACC (www.acc.org) and the AHA (www.americanheart.org). Reprints of this document (the complete guidelines) are available for $5 each by calling 800-253-4636 (US only) or writing the American College of Cardiology, Educational Services, 9111 Old Georgetown Road, Bethesda, MD 20814-1699. Ask for reprint No. 71-0164. To obtain a reprint of the shorter version (executive summary and summary of recommendations) published in the May 4, 1999, issue of Circulation, ask for reprint No. 71-0163. To purchase additional reprints (specify version and reprint number): up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 214-706-1466, fax 214-691-6342, or e-mail pubauth@heart.org

Glide:  A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy

Door-to-Needle Times for Tissue Plasminogen Activator Administration and Clinical Outcomes in Acute Ischemic Stroke Before and After a Quality Improvement Initiative

Matrix metalloproteinase activity is required for activity-induced angiogenesis in rat skeletal muscle

Percutaneous Coronary Intervention in the Elderly

ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

Integrin Signaling

Outcome in Elderly Patients Undergoing Primary Coronary Intervention for Acute Myocardial Infarction

Role of Prostacyclin in the Cardiovascular Response to Thromboxane A ₂

Impact of Sex and Contact‐to‐Device Time on Clinical Outcomes in Acute ST‐Segment Elevation Myocardial Infarction—Findings From the National Cardiovascular Data Registry

Matrix Metalloproteinase Inhibition After Myocardial Infarction

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Use of Strategies to Improve Door-to-Needle Times With Tissue-Type Plasminogen Activator in Acute Ischemic Stroke in Clinical Practice

ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)31This document was approved by the American College of Cardiology Board of Trustees in April 2001 and by the American Heart Association Science Advisory and Coordinating Committee in March 2001.32When citing this document, the American College of Cardiology and the American Heart Association would appreciate the following citation format: Smith SC, Jr, Dove JT, Jacobs AK, Kennedy JW, Kereiakes D, Kern MJ, Kuntz RE, Popma JJ, Schaff HV, Williams DO. ACC/AHA guidelines for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol 2001;37:2239i–lxvi.33This document is available on the ACC Web site at www.acc.organd the AHA Web site at www.americanheart.org(ask for reprint no. 71-0206). To obtain a reprint of the shorter version (executive summary and summary of recommendations) to be published in the June 15, 2001 issue of the Journal of the American College of Cardiology and the June 19, 2001 issue of Circulation for $5 each, call 800-253-4636 (US only) or write the American College of Cardiology, Educational Services, 9111 Old Georgetown Road, Bethesda, MD 20814-1699. To purchase additional reprints up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1,000 or more copies, call 214-706-1466, fax 214-691-6342, or E-mail: pubauth@heart.org(ask for reprint no. 71-0205).

Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Induction of vascular smooth muscle cell tenascin-C gene expression by denatured type I collagen is dependent upon a β3 integrin-mediated mitogen-activated protein kinase pathway and a 122-base pair promoter element

ACCF/AHA New Insights Into the Methodology of Performance Measurement

How Matrix Metalloproteinases Regulate Cell Behavior

Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases

2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention

Design and Therapeutic Application of Matrix Metalloproteinase Inhibitors

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

Medication Adherence

Glide:  A New Approach for Rapid, Accurate Docking and Scoring. 2. Enrichment Factors in Database Screening

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

Principles From Clinical Trials Relevant to Clinical Practice: Part I

ACC/AHA Guidelines for Percutaneous Coronary Intervention (Revision of the 1993 PTCA Guidelines)—Executive Summary

Role of Extracellular Matrix in Adaptation of Tendon and Skeletal Muscle to Mechanical Loading

Weekend versus Weekday Admission and Mortality from Myocardial Infarction

THE CHALLENGE OF HEALTH CARE DELIVERY TO THE ELDERLY PATIENT WITH CARDIOVASCULAR DISEASE

Bleeding risks with abciximab after full-dose thrombolysis in rescue or urgent angioplasty for acute myocardial infarction

A comparison of U.S. and Canadian cardiac catheterization practices in detecting severe coronary artery disease after myocardial infarction: efficiency, yield and long-term implications

Safety and efficacy of only 2 weeks of ticlopidine therapy in patients at increased risk of coronary stent thrombosis: Results from the Antiplatelet Therapy alone versus Lovenox plus Antiplatelet therapy in patients at increased risk of Stent Thrombosis (ATLAST) trial

A randomized, placebo-controlled trial of enoxaparin after high-risk coronary stenting: the ATLAST trial

A comparison of ionic versus nonionic contrast medium during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction (GUSTO IIb)

A Novel Bioresorbable Polymer Paclitaxel-Eluting Stent for the Treatment of Single and Multivessel Coronary Disease

The extracellular matrix in balloon arterial injury: A novel target for restenosis prevention

A Campaign to Improve the Timeliness of Primary Percutaneous Coronary Intervention

Contemporary outcome trends in the elderly undergoing percutaneous coronary interventions: Results in 7,472 octogenarians

Randomized COMparison of Platelet Inhibition With Abciximab, TiRofiban and Eptifibatide During Percutaneous Coronary Intervention in Acute Coronary Syndromes

Early and Late Quantitative Angiographic Results of Vein Graft Lesions Treated by Excimer Laser With Adjunctive Balloon Angioplasty

Chaparral-induced hepatic injury.

In Vivo Collagen Turnover Following Experimental Balloon Angioplasty Injury and the Role of Matrix Metalloproteinases